Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
The final provisions for the The Sunshine Act, which requires pharmaceutical and medical device manufacturers to track and publicly report what they spend on physicians at their meetings, were released February 1. Here’s a rundown of how the...
What you need to know to successfully negotiate a contract for your meeting, from knowing what you absolutely must have (as opposed to what you want), to rooms-to-space ratios, to concessions and addenda—plus a primer on the role a hotel'...
The Society for Worldwide Medical Exchange has released a country-by-country online compendium of pharmaceutical codes and continuing medical education rules and regulations. Called The Red Book for Medical Meetings, the guide has been endorse...
Taking a pharmaceutical meeting outside the U.S. can get complicated as you have to consider the meeting's host country's rules around payments to healthcare providers, as well as those of the HCPs' home countries. This article offers...
The Physician Payment Sunshine Act, Section 6002 of the Patient Protection and Affordable Care Act, which will require pharmaceutical companies to track and publicly report what they spend on healthcare providers, is still in limbo as of the f...
